These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1510643)

  • 1. Effect of high terrestrial altitude and supplemental oxygen on human performance and mood.
    Crowley JS; Wesensten N; Kamimori G; Devine J; Iwanyk E; Balkin T
    Aviat Space Environ Med; 1992 Aug; 63(8):696-701. PubMed ID: 1510643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between symptoms, moods, performance, and acute mountain sickness at 4,700 meters.
    Shukitt-Hale B; Banderet LE; Lieberman HR
    Aviat Space Environ Med; 1991 Sep; 62(9 Pt 1):865-9. PubMed ID: 1930076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dexamethasone and high terrestrial altitude on cognitive performance and affect.
    Jobe JB; Shukitt-Hale B; Banderet LE; Rock PB
    Aviat Space Environ Med; 1991 Aug; 62(8):727-32. PubMed ID: 1930053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation-dependent symptom, mood, and performance changes produced by exposure to hypobaric hypoxia.
    Shukitt-Hale B; Banderet LE; Lieberman HR
    Int J Aviat Psychol; 1998; 8(4):319-34. PubMed ID: 11542275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
    Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
    Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General introduction to altitude adaptation and mountain sickness.
    Bärtsch P; Saltin B
    Scand J Med Sci Sports; 2008 Aug; 18 Suppl 1():1-10. PubMed ID: 18665947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of chemical defense clothing and high terrestrial altitudes on lift/carry and marksmanship performance.
    Muza SR; Jackson R; Rock PB; Roach J; Lyons T; Cymerman A
    Aviat Space Environ Med; 2000 Jul; 71(7):668-77. PubMed ID: 10902929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altitude symptomatology and mood states during a climb to 3,630 meters.
    Shukitt-Hale B; Rauch TM; Foutch R
    Aviat Space Environ Med; 1990 Mar; 61(3):225-8. PubMed ID: 2317176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxygen supplementation on acute mountain sickness symptoms and functional capacity during a 2-kilometer walk test on Chajnantor plateau (5050 meters, Northern Chile).
    Silva-Urra JA; Urizar C; Basualto-Alarcón C; Torrella JR; Pagés T; Behn C; Viscor G
    Wilderness Environ Med; 2011 Sep; 22(3):250-6. PubMed ID: 21962052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood states at 1600 and 4300 meters terrestrial altitude.
    Shukitt BL; Banderet LE
    Aviat Space Environ Med; 1988 Jun; 59(6):530-2. PubMed ID: 3390110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of altitude pre-acclimatization on acute mountain sickness during reexposure.
    Lyons TP; Muza SR; Rock PB; Cymerman A
    Aviat Space Environ Med; 1995 Oct; 66(10):957-62. PubMed ID: 8526832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of acute mountain sickness during "rapid ascent" trekking to extreme altitude.
    Mistry G; Chandrashekhar Y; Sen U; Anand IS
    J Assoc Physicians India; 1993 Aug; 41(8):500-2. PubMed ID: 8294352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery.
    Lysakowski C; Von Elm E; Dumont L; Junod JD; Tassonyi E; Kayser B; Tramèr MR
    Clin Sci (Lond); 2004 Mar; 106(3):279-85. PubMed ID: 14572304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different stay durations on attentional performance during two mountain expeditions.
    Bonnon M; Noël-Jorand MC; Therme P
    Aviat Space Environ Med; 2000 Jul; 71(7):678-84. PubMed ID: 10902930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and therapy of altitude sickness].
    Maggiorini M
    Ther Umsch; 1993 Apr; 50(4):221-7. PubMed ID: 8378872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
    Vardy J; Vardy J; Judge K
    Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
    Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute mountain sickness in children and their parents after rapid ascent to 3500 m (Putre, Chile).
    Moraga FA; Pedreros CP; Rodríguez CE
    Wilderness Environ Med; 2008; 19(4):287-92. PubMed ID: 19099320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute mountain sickness at 3500 and 4250 m. A study of symptom, incidence and severity].
    Vargas M; Osorio J; Jiménez D; Moraga F; Sepúlveda M; Del Solar J; Hudson C; Cortés G; León A
    Rev Med Chil; 2001 Feb; 129(2):166-72. PubMed ID: 11351468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness.
    Dorward DA; Thompson AA; Baillie JK; MacDougall M; Hirani N
    Respir Med; 2007 Mar; 101(3):587-94. PubMed ID: 16890420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.